{
  "documentMetadata": {
    "title": "Candidiasis, Oropharyngeal",
    "sourceFile": "syndromes/head_and_neck/Candidiasis, Oropharyngeal.pdf",
    "lastUpdated": "2024-03-27"
  },
  "content": [
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Thrush: creamy white patches overlying inflamed mucosa of buccal and pharyngeal mucosa, palate, and tonsils.",
        "Erythematous variant with flat erythematous lesions.",
        "Angular cheilitis with erythematous fissures in the corners of the mouth."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Candida albicans",
        "Other non-albicans Candida sp."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Mild disease:"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Clotrimazole troches",
                "dose": "10 mg",
                "frequency": "5x/day",
                "connector": "or"
              },
              {
                "drug": "Nystatin suspension",
                "dose": "500,000 units (5 mL)",
                "frequency": "swish & swallow qid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "7-14 days"
            }
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Moderate-severe disease and/or HIV-positive patient:"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Fluconazole",
                "dose": "100-200 mg/day"
              }
            ],
            "durationDetail": {
              "fixedDuration": "7-14 days"
            }
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "Itraconazole solution 200 mg po daily x 7-14 days",
        "Voriconazole 200 mg q12h x 7-14 days",
        "Isavuconazonium sulfate (prodrug of Isavuconazole) 372 mg po/IV q8h x 6 doses and then 372 mg po/IV daily",
        "Posaconazole (NOTE: different dosing delayed release tabs/IV vs. suspension, better levels achieved with delayed-release tabs)",
        "  Delayed-release tabs 300 mg po bid x 2 doses and then 300 mg po daily",
        "  Suspension 200 mg qid, then 400 mg po bid after stabilization of disease",
        "  Posaconazole IV 300 mg IV over 90 minutes bid x 1 day, then 300 mg IV daily",
        "Caspofungin 70 mg loading dose, then 50 mg/day IV or Micafungin 100 mg/day IV or Anidulafungin 200 mg IV loading dose, then 100 mg/day IV x 7-14 days",
        "Amphotericin B 0.3 mg/kg/day x 7-14 days"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "HIV-positive patients: Antiretroviral therapy (ART) is recommended to prevent recurrent disease.",
        "Suppressive therapy in select immunocompromised patients with recurrent disease: Fluconazole 100 mg po 3x/week.",
        "Dysphagia or odynophagia is predictive of esophageal candidiasis.",
        "IDSA treatment guidelines: Clin Infect Dis 62:409, 2016"
      ]
    }
  ]
}
